Search results
'It was devastating' | Arkansas woman overcomes oral cancer as cases rise in US
KTHV Little Rock· 4 days agoNew data from the American Cancer Society indicates a rise in oral cancer diagnoses in Arkansas and...
Congenital Pigment Disorders May Need Special Management
Medscape· 2 days agoCongenital disorders of pigmentation are numerous and can have mild to severe effects, and some have...
Lichen Planopilaris: Prevalence, Treatments in the US
Medscape· 3 days agoMost patients diagnosed with LPP received at least one type of medication, most commonly...
Former Aggie RB Darren Lewis turns life around and is now fighting for it
The Bryan-College Station Eagle· 2 days agoThe 5-foot-10, 219-pound Lewis was virtually unstoppable from the first time he walked onto a...
GENMAB A/S/S (OTCMKTS:GMXAY) and LianBio (NASDAQ:LIAN) Critical Contrast
ETF DAILY NEWS· 4 days agoLianBio (NASDAQ:LIAN – Get Free Report) and GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses ...
Cantor Fitzgerald L. P. Has $362,000 Stock Holdings in Adlai Nortye Ltd. (NASDAQ:ANL)
ETF DAILY NEWS· 2 days agoCantor Fitzgerald L. P. boosted its position in Adlai Nortye Ltd. (NASDAQ:ANL – Free Report) by 128.2% during the fourth quarter, according to the company in its most recent 13F filing with ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 5 days agoFlamingo Therapeutics Announces Poster Presentation at EACR 2024 Congress on FLM-7523 (FTX-001), a First-in-Class Inhibitor of the Long Non-Coding RNA MALAT1 PR Newswire LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, June 10, 2024 LEUVEN
Merus N.V. VP controller Harry Shuman sells shares worth over $475,000 By Investing.com
Investing.com· 3 days agoIn a recent transaction, Harry Shuman, the VP Controller and Principal Accounting Officer (PAO) of...
Birchview Capital LP Invests $216,000 in Castle Biosciences, Inc. (NASDAQ:CSTL)
ETF DAILY NEWS· 2 days agoBirchview Capital LP acquired a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 10,000 shares ...
Replimune Group (NASDAQ:REPL) Shares Up 4.1% on Analyst Upgrade
ETF DAILY NEWS· 5 days agoReplimune Group, Inc. (NASDAQ:REPL – Get Free Report) shares traded up 4.1% during trading on Monday after Barclays raised their price target on the stock from $13.00 to $17.00. Replimune Group ...